North Carolina
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
Asian or Pacific Islander individuals in North Carolina are least likely to be diagnosed early.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases is 62.9 and significantly higher than the national rate of 53.6.
- North Carolina ranks 41stamong all states, placing it in the below average tier.
- Over the last five years, the rate of new cases improved by 14%.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in North Carolina is 27.7%, which is not significantly different than the national rate of 28.4%.
- It ranks 23rd among the 47 states with survival data, placing it in the average tier.
- Over the last five years, the survival rate in North Carolina improved by 26%.
Early Diagnosis:
- 27.4% of cases are caught at an early stage, which is not significantly different than the national rate of 27.4%.
- It ranks 26th among the 47 states with data on diagnosis at an early stage, placing it in the average tier.
- Over the last five years, the early diagnosis rate in North Carolina improved by 10%.
Lung Cancer Treatment
Surgical Treatment:
- North Carolina ranked 26th (out of the 47 states with available data) with 19.4% of cases undergoing surgery as part of the first course of treatment.
- This is significantly lower than the national rate of 20.7% and puts North Carolina in the average tier.
- Over the last five years, the percent of cases undergoing surgery in North Carolina did not change significantly.
Biomarker Coverage:
- North Carolina has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of September 2024.
Lack of Treatment:
- North Carolina ranked 10th (out of the 47 states with available data) with 17.4% of cases not receiving any treatment.
- This is significantly lower than the national rate of 20.9% and puts North Carolina in the above average tier.
- Over the last five years, the percent of cases receiving no treatment in North Carolina did not change significantly.
Screening
Screening for High Risk:
- In North Carolina, 17.2% of those at high risk were screened, which was not significantly different than the national rate of 16.0%.
- It ranks 18th among all states, placing it in the average tier.
Prevention
Tobacco Use:
- The smoking rate in North Carolina is 14.5% and not significantly different than the national rate of 12.9%.
- It ranks 28th among all states, placing it in the average tier.
Radon:
- In North Carolina, 13.5% of radon tests results were at or above the action level recommended by EPA.
- It ranks 13th among all states, placing it in the above average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 61.2 per 100,000 population among Black individuals in North Carolina, significantly higher than the rate of 55.1 among Black individuals nationally, and significantly lower than the rate of 65.2 among white individuals in North Carolina.
- The five-year survival rate is 26.7% among Black individuals in North Carolina, not significantly different than the rate of 25.5% among Black individuals nationally, and not significantly different than the rate of 27.8% among white individuals in North Carolina.
- 24.5% of lung cancer cases are diagnosed at an early stage among Black individuals in North Carolina, not significantly different than the rate of 24.1% among Black individuals nationally, and significantly lower than the rate of 28.3% among white individuals in North Carolina.
- 16.8% of Black individuals with lung cancer in North Carolina underwent surgery, not significantly different than the rate of 17.0% among Black individuals nationally, and significantly lower than the rate of 20.0% among white individuals in North Carolina.
- 16.7% of Black individuals with lung cancer in North Carolina did not receive any treatment, significantly lower than the rate of 22.7% among Black individuals nationally, and not significantly different than the rate of 17.6% among white individuals in North Carolina.
Latino individuals:
- The rate of new lung cancer cases is 27.4 per 100,000 population among Latino individuals in North Carolina, not significantly different than the rate of 28.1 among Latino individuals nationally, and significantly lower than the rate of 65.2 among white individuals in North Carolina.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
- 23.6% of lung cancer cases are diagnosed at an early stage among Latino individuals in North Carolina, not significantly different than the rate of 23.5% among Latino individuals nationally, and significantly lower than the rate of 28.3% among white individuals in North Carolina.
- 22.6% of Latino individuals with lung cancer in North Carolina underwent surgery, not significantly different than the rate of 21.3% among Latino individuals nationally, and significantly higher than the rate of 20.0% among white individuals in North Carolina.
- 14.9% of Latino individuals with lung cancer in North Carolina did not receive any treatment, significantly lower than the rate of 26.3% among Latino individuals nationally, and not significantly different than the rate of 17.6% among white individuals in North Carolina.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 28.7 per 100,000 population among Asian or Pacific Islanders individuals in North Carolina, significantly lower than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 65.2 among white individuals in North Carolina.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- 19.3% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in North Carolina, not significantly different than the rate of 23.4% among Asian or Pacific Islander individuals nationally, and significantly lower than the rate of 28.3% among white individuals in North Carolina.
- 20.1% of Asian or Pacific Islander individuals with lung cancer in North Carolina underwent surgery, significantly lower than the rate of 24.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 20.0% among white individuals in North Carolina.
- 14.8% of Asian or Pacific Islander individuals with lung cancer in North Carolina did not receive any treatment, significantly lower than the rate of 20.1% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 17.6% among white individuals in North Carolina.
Indigenous Peoples:
- The rate of new lung cancer cases is 68.4 per 100,000 population among Indigenous Peoples (American Indians/Alaska Natives) in North Carolina, significantly higher than the rate of 39.9 among Indigenous Peoples nationally, and not significantly different than the rate of 65.2 among white individuals in North Carolina.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
- 22.9% of lung cancer cases are diagnosed at an early stage among Indigenous Peoples (American Indians/Alaska Natives) in North Carolina, not significantly different than the rate of 24.7% among Indigenous Peoples (American Indians/Alaska Natives) nationally, and significantly lower than the rate of 28.3% among white individuals in North Carolina.
- 15.5% of Indigenous Peoples (American Indians/Alaska Natives) with lung cancer in North Carolina underwent surgery, not significantly different than the rate of 16.0% among Indigenous Peoples (American Indians/Alaska Natives) nationally, and significantly lower than the rate of 20.0% among white individuals in North Carolina.
- 19.3% of Indigenous Peoples (American Indians/Alaska Natives) with lung cancer in North Carolina did not receive any treatment, significantly lower than the rate of 24.3% among Indigenous Peoples (American Indians/Alaska Natives) nationally, and not significantly different than the rate of 17.6% among white individuals in North Carolina.
Summary
Despite the early diagnosis rate in North Carolina falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
North Carolina has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
North Carolina falls into the above average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: November 12, 2024